Author:
Montecalvo Angela,Gambotto Andrea,D’Aiuto Leonardo
Reference74 articles.
1. Amalfitano, A., McVie-Wylie, A.J., Hu, H., Dawson, T.L., Raben, N., Plotz, P., and Chen, Y.T. (1999) Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-alpha-glucosidase. Proc Natl Acad Sci U S A. 96, 8861-8866.
2. Barr, D., Tubb, J., Ferguson, D., Scaria, A., Lieber, A., Wilson C., Perkins, J., and Kay, M.A. (1995) Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: Comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 2, 151-155.
3. Bessis, N., GarciaCozar, F.J., and Boissier, M.-C. (2004) Immune response to gene therapy vectors: influence on vector function and effectors mechanisms. Gene Ther. 11, 10-17.
4. Cheng, S.H. and Smith, A.E. (2003) Gene therapy progress and prospects: Gene delivery of lysosomal storage disorders. Gene Ther. 10, 1275-1281.
5. Chirmule, N., Propert, K., Magosin, S., Qian, Y., Qian, R. and Wilson, J. (1999) Immune responses to adenovirus and adeno-associated virus in humans. Gene Ther. 6, 1574-1583.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献